202 related articles for article (PubMed ID: 15815043)
1. Fusarium verticillioides abscess of the nasal septum in an immunosuppressed child: case report and identification of the morphologically atypical fungal strain.
Dornbusch HJ; Buzina W; Summerbell RC; Lass-Flörl C; Lackner H; Schwinger W; Sovinz P; Urban C
J Clin Microbiol; 2005 Apr; 43(4):1998-2001. PubMed ID: 15815043
[TBL] [Abstract][Full Text] [Related]
2. Treating disseminated fusariosis: amphotericin B, voriconazole or both?
Ho DY; Lee JD; Rosso F; Montoya JG
Mycoses; 2007 May; 50(3):227-31. PubMed ID: 17472622
[TBL] [Abstract][Full Text] [Related]
3. Antifungal susceptibility profile of clinical Fusarium spp. isolates identified by molecular methods.
Alastruey-Izquierdo A; Cuenca-Estrella M; Monzón A; Mellado E; Rodríguez-Tudela JL
J Antimicrob Chemother; 2008 Apr; 61(4):805-9. PubMed ID: 18263569
[TBL] [Abstract][Full Text] [Related]
4. Treatment of murine Fusarium verticillioides infection with liposomal amphotericin B plus terbinafine.
Ruíz-Cendoya M; Pastor FJ; Capilla J; Guarro J
Int J Antimicrob Agents; 2011 Jan; 37(1):58-61. PubMed ID: 20947310
[TBL] [Abstract][Full Text] [Related]
5. High genetic diversity and poor in vitro response to antifungals of clinical strains of Fusarium oxysporum.
Azor M; Cano J; Gené J; Guarro J
J Antimicrob Chemother; 2009 Jun; 63(6):1152-5. PubMed ID: 19318361
[TBL] [Abstract][Full Text] [Related]
6. Effect of voriconazole on a corneal abscess caused by fusarium.
Polizzi A; Siniscalchi C; Mastromarino A; Saccà SC
Acta Ophthalmol Scand; 2004 Dec; 82(6):762-4. PubMed ID: 15606478
[TBL] [Abstract][Full Text] [Related]
7. A case of fusariosis in an immunocompromised patient successfully treated with liposomal amphotericin B.
Selleslag D
Acta Biomed; 2006; 77 Suppl 2():32-5. PubMed ID: 16918066
[TBL] [Abstract][Full Text] [Related]
8. Combined therapy in treatment of murine infection by Fusarium solani.
Ruíz-Cendoya M; Mariné M; Guarro J
J Antimicrob Chemother; 2008 Sep; 62(3):543-6. PubMed ID: 18495651
[TBL] [Abstract][Full Text] [Related]
9. A case of invasive rhinosinusitis by Fusarium verticillioides (Saccardo) Nirenberg in an apparently immunocompetent patient.
Macêdo DP; Neves RP; Fontan J; Souza-Motta CM; Lima D
Med Mycol; 2008 Aug; 46(5):499-503. PubMed ID: 18608897
[TBL] [Abstract][Full Text] [Related]
10. In vitro antifungal susceptibility and molecular characterization of clinical isolates of Fusarium verticillioides (F. moniliforme) and Fusarium thapsinum.
Azor M; Gené J; Cano J; Sutton DA; Fothergill AW; Rinaldi MG; Guarro J
Antimicrob Agents Chemother; 2008 Jun; 52(6):2228-31. PubMed ID: 18391027
[TBL] [Abstract][Full Text] [Related]
11. A dark strain in the Fusarium solani species complex isolated from primary subcutaneous sporotrichioid lesions associated with traumatic inoculation via a rose bush thorn.
Kantarcioglu AS; Summerbell RC; Sutton DA; Yücell A; Sarikaya E; Kaner G; Iscimen A; Altas K
Med Mycol; 2010 Feb; 48(1):103-9. PubMed ID: 20055744
[TBL] [Abstract][Full Text] [Related]
12. Successful voriconazole therapy of disseminated Fusarium verticillioides infection in an immunocompromised patient receiving chemotherapy.
Sagnelli C; Fumagalli L; Prigitano A; Baccari P; Magnani P; Lazzarin A
J Antimicrob Chemother; 2006 Apr; 57(4):796-8. PubMed ID: 16469850
[No Abstract] [Full Text] [Related]
13. Disseminated fusariosis caused by Fusarium verticillioides in an acute lymphoblastic leukemia patient after allogeneic hematopoietic stem cell transplantation.
Tezcan G; Ozhak-Baysan B; Alastruey-Izquierdo A; Ogunc D; Ongut G; Yildiran ST; Hazar V; Cuenca-Estrella M; Rodriguez-Tudela JL
J Clin Microbiol; 2009 Jan; 47(1):278-81. PubMed ID: 19005150
[TBL] [Abstract][Full Text] [Related]
14. [Vitrectomy in the treatment of endogenous fungal endophthalmitis in a patient after renal transplantation].
Oficjalska-Młyńczak J; Turno-Krecicka A; Muzyka-Woźniak M; Teklak D
Klin Oczna; 2003; 105(5):303-6. PubMed ID: 14746184
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of Fusarium solani hyphae and conidia susceptibility to amphotericin B and itraconazole: study of a clinical case.
Teixeira AB; Moretti ML; Trabasso P; von Nowakonski A; Aoki FH; Vigorito AC; Miyaji M; Nishimura K; Taguchi H; Schreiber AZ
Mycopathologia; 2005 Nov; 160(4):291-6. PubMed ID: 16244897
[TBL] [Abstract][Full Text] [Related]
16. The polypore mushroom Irpex lacteus, a new causative agent of fungal infections.
Buzina W; Lass-Flörl C; Kropshofer G; Freund MC; Marth E
J Clin Microbiol; 2005 Apr; 43(4):2009-11. PubMed ID: 15815046
[TBL] [Abstract][Full Text] [Related]
17. Species distribution and in vitro antifungal susceptibility patterns of 75 clinical isolates of Fusarium spp. from northern Italy.
Tortorano AM; Prigitano A; Dho G; Esposto MC; Gianni C; Grancini A; Ossi C; Viviani MA
Antimicrob Agents Chemother; 2008 Jul; 52(7):2683-5. PubMed ID: 18443107
[TBL] [Abstract][Full Text] [Related]
18. Perinephric abscess caused by Fusarium chlamydosporum in an immunocompetent child: case report and identification of the morphologically atypical fungal strain.
Sidhu S; Chander J; Singh K
Indian J Pathol Microbiol; 2013; 56(3):312-4. PubMed ID: 24152521
[TBL] [Abstract][Full Text] [Related]
19. Successful treatment of Fusarium keratitis with cornea transplantation and topical and systemic voriconazole.
Klont RR; Eggink CA; Rijs AJ; Wesseling P; Verweij PE
Clin Infect Dis; 2005 Jun; 40(12):e110-2. PubMed ID: 15909252
[TBL] [Abstract][Full Text] [Related]
20. Less-frequent Fusarium species of clinical interest: correlation between morphological and molecular identification and antifungal susceptibility.
Azor M; Gené J; Cano J; Manikandan P; Venkatapathy N; Guarro J
J Clin Microbiol; 2009 May; 47(5):1463-8. PubMed ID: 19321723
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
